F50 Trial
Evaluating the safety and tolerability of lower-calorie therapeutic milk during early stabilisation of critically ill children with severe malnutrition.
Current, follow-on and completed research advancing child nutrition, survival and recovery.
Evaluating the safety and tolerability of lower-calorie therapeutic milk during early stabilisation of critically ill children with severe malnutrition.
A multinational collaboration studying why acutely ill or undernourished young children remain at risk during hospitalisation and for months after discharge.
Integrated biological research investigating mechanisms associated with mortality among acutely ill children.
Testing whether pancreatic enzymes and bile-acid treatment improve outcomes in hospitalised children with severe acute malnutrition.
Minimally invasive tissue sampling improved cause-of-death attribution among children with acute illness and/or severe malnutrition.
Improving recognition and classification of skin manifestations associated with childhood malnutrition.
Using the hospital stay to strengthen caregiving for children admitted with severe acute malnutrition.
Investigating whether one egg per day improves growth, development and nutritional biomarkers.
Comparing therapeutic-food formulations for severe acute malnutrition and subsequent neurodevelopment.
Examining body composition, cardiometabolic risk and physical activity after treatment for acute malnutrition.
Evaluating multiple micronutrient powder delivered with infant and young-child feeding education.
Research extends beyond the hospital door to understand recovery and risk after discharge.
Research history note: COSMIC, ATOMIC and other related studies will be added when investigator-approved summaries are available.
Partner with MNRG to turn important nutrition questions into meaningful evidence and better outcomes.